Aims: We investigated the antibacterial efficacy of Umonium and Virkon against Burkholderia pseudomallei, Escherichia coli, Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus (MRSA) up to 14 days following treatment.
Methods And Results: Umonium was diluted to 0.5%, 1.